Answer
The product information for Tagrisso 40 mg film-coated tablets (osimertinib mesylate) states that pharmaceutical incompatibilities are “Not applicable.”
Sources for this answer
- Tagrisso 40 mg film-coated tabletsAstraZeneca UK Limited · emc · SmPC §6.2 Incompatibilities · Version 33Document updated
Sources checked